Infect Chemother.  2018 Sep;50(3):263-265. 10.3947/ic.2018.50.3.263.

Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”

• Lee CH

• KMID: 2420910
• DOI: http://doi.org/10.3947/ic.2018.50.3.263

Abstract

No abstract available.

MeSH Terms

Bronchoalveolar Lavage Fluid*
Bronchoalveolar Lavage*
Lymphocytes*
Pneumocystis jirovecii*
Pneumocystis*
Risk Factors*

Reference

1. Kim T, Sung H, Chong YP, Kim SH, Choo EJ, Choi SH, Kim TH, Woo JH, Kim YS, Lee SO. Low lymphocyte proportion in bronchoalveolar lavage fluid as a risk factor associated with the change from trimethoprim/sulfamethoxazole used as first-line treatment for Pneumocystis jirovecii pneumonia. Infect Chemother. 2018; 50:110–119. PMID: 29968978.

2. Smego RA Jr, Nagar S, Maloba B, Popara M. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med. 2001; 161:1529–1533. PMID: 11427101.

3. Gruden JF, Huang L, Turner J, Webb WR, Merrifield C, Stansell JD, Gamsu G, Hopewell PC. High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol. 1997; 169:967–975. PMID: 9308446.